Dr. Sara Schaefer speaks with Dr. Caroline Olvera about trending videos of tics and other neurological syndromes on social media. Read the article

Dr. Sara Schaefer speaks with Dr. Carlos Camargo about the non-motor and prodromal features of dystonia. Read the article

Dr. Michele Matarazzo interviews Prof. Gilberto Fisone about the role of autophagy in levodopa-induced dyskinesia. Read the article

Dr. Matarazzo interviews Dr. Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease.

Dr. Sara Schaefer discusses with Dr. Pedro Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders. Read the article

Dr. Michele Matarazzo interviews Dr. Nicola Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease. Read the article

Dr. Michele Matarazzo interviews Dr. Rosa De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the Movement Disorders journal.Read the article

Dr. Sara Schaefer speaks with Dr. Nicola Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions. Read the article

Dr. Yiwen Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs. Read the article

Dr. Mcihele Matarazzo interviews Dr. David Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets. Read the article